Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem

RTS,S is a malaria vaccine. It is the world's first licensed malaria vaccine and also the first vaccine licensed for use against a human parasitic disease of any kind.

Its efficacy ranges from 26 to 50% in infants and young children.^[1]

In October 2021, the vaccine was supported by the World Health Organization for large use in children, making it the first malaria vaccine candidate, and first vaccine to fight against the parasitic infection, to receive this recommendation.^[2]^[3]^[4]

References

↑ "Pilot implementation of first malaria vaccine recommended by WHO advisory groups".
↑ Davies, Lizzy (6 October 2021). "WHO endorses use of world's first malaria vaccine in Africa". The Guardian. Retrieved 6 October 2021.
↑ Drysdale, Carla; Kelleher, Kristen. "WHO recommends groundbreaking malaria vaccine for children at risk". World Health Organization. Retrieved 6 October 2021.
↑ Mandavilli, Apoorva (October 6, 2021). "A 'Historical Event': First Malaria Vaccine Approved by W.H.O." New York Times. Retrieved October 6, 2021.

[1] "Pilot implementation of first malaria vaccine recommended by WHO advisory groups".

[2] Davies, Lizzy (6 October 2021). "WHO endorses use of world's first malaria vaccine in Africa". The Guardian. Retrieved 6 October 2021.

[3] Drysdale, Carla; Kelleher, Kristen. "WHO recommends groundbreaking malaria vaccine for children at risk". World Health Organization. Retrieved 6 October 2021.

[4] Mandavilli, Apoorva (October 6, 2021). "A 'Historical Event': First Malaria Vaccine Approved by W.H.O." New York Times. Retrieved October 6, 2021.

[1]

[2]

[3]

[4]